☆ 4.6 Letter

Recurrence of conjunctival goblet cells after discontinuation of dupilumab in a patient with dupilumab-related conjunctivitis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)

Related references

Note: Only part of the references are listed.

Article Dermatology

Conjunctivitis in dupilumab clinical trials

B. Akinlade et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Letter Dermatology

Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitis

D. S. Bakker et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Add to Collection

Article Ophthalmology

Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye

Yu Jeong Kim et al.

CORNEA (2016)

Add to Collection

© Peeref 2019-2024. All rights reserved.